Schizophrenia Drugs Market Size to Witness Healthy Valuation of US$ 12.6 Billion at 5.6% CAGR by 2032 | Market.us Report
25. Mai 2023 07:54 ET
|
Market.Us
New York, May 25, 2023 (GLOBE NEWSWIRE) -- As per this latest study by Market.us, The global Schizophrenia Drugs Market was valued at US$ 7.4 Bn in 2022. It is projected to expand at a CAGR of 5.6%...
Global Schizophrenia Drug Market Size To Grow USD 11.8 Billion By 2030 | CAGR of 3.3%
16. März 2023 06:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , March 16, 2023 (GLOBE NEWSWIRE) -- The Global Schizophrenia Drug Market Size to grow from USD 9.1 billion in 2021 to USD 11.80 billion by 2030, at a Compound Annual Growth...
Schizophrenia Drugs Market Report (2022 to 2030) - H. Lundbeck A/S, Bristol-Myers Squibb Company, Eli Lilly and Company, AstraZeneca plc, Pfizer Inc. and Among Others
12. Oktober 2022 06:16 ET
|
Growth Plus Reports
Pune, Oct. 12, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Schizophrenia Drugs Market by Drug Class (1st Generation Antipsychotics, 2nd Generation Antipsychotics, 3rd...
Schizophrenia Drugs Market Is Expected to Reach $12.53 Billion by 2031, Says Allied Market Research
02. September 2022 11:00 ET
|
Allied Market Research
Portland, OR, Sept. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global schizophrenia drugs market generated $7.16 billion in 2021 and is estimated...
Global Schizophrenia Drugs market: Aripiprazole is Most Prescribed Drug in 2021 | SkyQuest Technology
04. August 2022 09:40 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Schizophrenia affects about 1% of the population and is predicted to become more common in the future as the world becomes crowded and people live...
Schizophrenia Drugs Market Is Predicted to Reach USD 9.48 Billion by 2026; Launch of REXULTI Tablets by Otsuka Pharmaceutical Co., Ltd., Will Accelerate Growth, says Fortune Business Insights
11. Oktober 2019 06:03 ET
|
Fortune Business Insights
Pune, Oct. 11, 2019 (GLOBE NEWSWIRE) -- The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the global Schizophrenia Drugs Market, says Fortune...